BioPlan Associates, Inc., has published the 2015 “12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production.”

For the report, 238 biopharma companies were surveyed along with 164 suppliers to the industry, representing 30 countries.

This comprehensive survey covers biotherapeutic developers and contract manufacturing organizations’ current and projected future capacity and production capabilities. It includes 468 pages of data and analysis offered to help improve decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends and benchmarks.

Some of the areas covered include:

• Biosimilars pipeline in development
• In-depth analysis of key data, capacity, production trends, and benchmarks
• Budget trends and impact of current economic environment
• Expression system advances
• Downstream purification problems and issues
• Current and projected industry bottlenecks
• Capacity utilization and current production levels
• How capacity bottlenecks are being resolved
• Production trends and implications for industry
• Outsourcing trends
• International offshoring through 2017
• Range of titres, growth
• Disposables: Spending growth; downstream uses; L&E’s; reasons for increasing/ restricting; budget increases; vendor satisfaction
• Disposables: Compare innovators vs CMOs & US vs Europe
• Batch failure rates & trends
• Selecting a CMO — Problems & solutions
• Quality management & PAT implementation
• Hiring and employment growth
• Supplier growth rates

For more information visit BioPlan Associates on the web here.